| NDC Code | 10019-991-01 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-991-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 10019-991 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Bortezomib |
|---|
| Non-Proprietary Name | Bortezomib |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS; SUBCUTANEOUS |
|---|
| Start Marketing Date | 20220502 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA213823 |
|---|
| Manufacturer | Baxter Healthcare Corporation |
|---|
| Substance Name | BORTEZOMIB |
|---|
| Strength | 3.5 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA] |
|---|